Although the majority of CCLE cell lines defined as SCLC-Y appear to be SMARCA4-deficient malignancies, this is likely because these tumors were diagnosed historically, without access to immunohistochemical and molecular testing used today and before SMARCA4-deficient lung malignancies were a recognized disease entity. The gene discussed is SMARCA4; the disease is small cell lung carcinoma.